Literature DB >> 17826908

Neurosteroids reduce inflammation after TBI through CD55 induction.

Jacob W VanLandingham1, Milos Cekic, Sarah Cutler, Stuart W Hoffman, Donald G Stein.   

Abstract

The inflammatory cascade that follows traumatic brain injury may lead to secondary cell death and can impede recovery of function. Complement factors and their convertases are increased in glia after brain injury and lead to the production of inflammatory products that kill vulnerable neurons. Progesterone and its metabolite allopregnanolone (5alpha-pregnan-3beta-ol-20-one) have been shown to reduce the expression of inflammatory cytokines in the acute stages of brain injury, although how they do this is not completely understood. In this study we show that both progesterone and allopregnanolone treatments enhance the production of CD55 following contusion injuries of the cerebral cortex in rats. CD55, a single-chain type 1 cell surface protein, is a potent inhibitor of the complement convertases which are activators of the inflammatory cascade. The increased expression of CD55 could be an important mechanism by which steroids help to reduce the cerebral damage caused by inflammation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826908      PMCID: PMC2230083          DOI: 10.1016/j.neulet.2007.08.045

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  44 in total

1.  Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective.

Authors:  Iratxe Ciriza; Paloma Carrero; Cheryl A Frye; Luis M Garcia-Segura
Journal:  J Neurobiol       Date:  2006-08

Review 2.  Progesterone-induced neuroprotection.

Authors:  Meharvan Singh
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

Review 3.  Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems.

Authors:  Vita Birzniece; Torbjörn Bäckström; Inga-Maj Johansson; Charlotte Lindblad; Per Lundgren; Magnus Löfgren; Tommy Olsson; Gianna Ragagnin; Magdalena Taube; Sahruh Turkmen; Göran Wahlström; Ming-De Wang; Anna-Carin Wihlbäck; Di Zhu
Journal:  Brain Res Rev       Date:  2005-12-20

4.  Regulation of Bcl-2 and Bcl-xL anti-apoptotic protein expression by nuclear receptor PXR in primary cultures of human and rat hepatocytes.

Authors:  Nathalie Zucchini; Georges de Sousa; Béatrice Bailly-Maitre; Jean Gugenheim; Rémi Bars; Géraldine Lemaire; Roger Rahmani
Journal:  Biochim Biophys Acta       Date:  2005-03-18

5.  Complement component C3 mediates inflammatory injury following focal cerebral ischemia.

Authors:  J Mocco; William J Mack; Andrew F Ducruet; Sergei A Sosunov; Michael E Sughrue; Benjamin G Hassid; M Nathan Nair; Ilya Laufer; Ricardo J Komotar; M Claire; H Holland; David J Pinsky; E Sander Connolly
Journal:  Circ Res       Date:  2006-06-15       Impact factor: 17.367

6.  Differential behavioral and histopathological responses to graded cortical impact injury in mice.

Authors:  Kathryn E Saatman; Kristofer J Feeko; Rebecca L Pape; Ramesh Raghupathi
Journal:  J Neurotrauma       Date:  2006-08       Impact factor: 5.269

7.  Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats.

Authors:  Qingmin Guo; Iqbal Sayeed; Lon M Baronne; Stuart W Hoffman; Rachida Guennoun; Donald G Stein
Journal:  Exp Neurol       Date:  2006-01-27       Impact factor: 5.330

8.  Secondary ischemia impairing the restoration of ion homeostasis following traumatic brain injury.

Authors:  Michael F Stiefel; Yoshiyuki Tomita; Anthony Marmarou
Journal:  J Neurosurg       Date:  2005-10       Impact factor: 5.115

9.  Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury.

Authors:  Iris Leinhase; Oliver I Schmidt; Joshua M Thurman; Amir M Hossini; Michal Rozanski; Mohy E Taha; Alice Scheffler; Thilo John; Wade R Smith; V Michael Holers; Philip F Stahel
Journal:  Exp Neurol       Date:  2006-03-20       Impact factor: 5.330

10.  Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion.

Authors:  Iqbal Sayeed; Qingmin Guo; Stuart W Hoffman; Donald G Stein
Journal:  Ann Emerg Med       Date:  2006-02-21       Impact factor: 5.721

View more
  29 in total

1.  Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects.

Authors:  Jennifer C Naylor; Jason D Kilts; Christine M Hulette; David C Steffens; Dan G Blazer; John F Ervin; Jennifer L Strauss; Trina B Allen; Mark W Massing; Victoria M Payne; Nagy A Youssef; Lawrence J Shampine; Christine E Marx
Journal:  Biochim Biophys Acta       Date:  2010-05-19

Review 2.  Progesterone for neuroprotection in pediatric traumatic brain injury.

Authors:  Courtney L Robertson; Emin Fidan; Rachel M Stanley; Corina Noje; Hülya Bayir
Journal:  Pediatr Crit Care Med       Date:  2015-03       Impact factor: 3.624

Review 3.  Progesterone and vitamin d hormone as a biologic treatment of traumatic brain injury in the aged.

Authors:  Donald G Stein; Milos M Cekic
Journal:  PM R       Date:  2011-06       Impact factor: 2.298

4.  Progesterone and allopregnanolone attenuate blood-brain barrier dysfunction following permanent focal ischemia by regulating the expression of matrix metalloproteinases.

Authors:  Tauheed Ishrat; Iqbal Sayeed; Fahim Atif; Fang Hua; Donald G Stein
Journal:  Exp Neurol       Date:  2010-09-15       Impact factor: 5.330

Review 5.  Sex-related responses after traumatic brain injury: Considerations for preclinical modeling.

Authors:  Claudia B Späni; David J Braun; Linda J Van Eldik
Journal:  Front Neuroendocrinol       Date:  2018-05-18       Impact factor: 8.606

6.  Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.

Authors:  Ying Wang; Yansong Li; Shawn L Dalle Lucca; Milomir Simovic; George C Tsokos; Jurandir J Dalle Lucca
Journal:  J Neuroinflammation       Date:  2010-04-09       Impact factor: 8.322

Review 7.  Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup.

Authors:  Ramon Diaz-Arrastia; Patrick M Kochanek; Peter Bergold; Kimbra Kenney; Christine E Marx; Col Jamie B Grimes; L T C Yince Loh; L T C Gina E Adam; Devon Oskvig; Kenneth C Curley; Wanda Salzer
Journal:  J Neurotrauma       Date:  2014-01-15       Impact factor: 5.269

Review 8.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

9.  Effects of progesterone administration on infarct volume and functional deficits following permanent focal cerebral ischemia in rats.

Authors:  Tauheed Ishrat; Iqbal Sayeed; Fahim Atif; Donald G Stein
Journal:  Brain Res       Date:  2008-12-29       Impact factor: 3.252

10.  Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats.

Authors:  Milos Cekic; Sarah M Cutler; Jacob W VanLandingham; Donald G Stein
Journal:  Neurobiol Aging       Date:  2009-05-30       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.